---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-023719"
form_type: "8-K"
ticker: "AMS"
cik: "0000744825"
company_name: "AMERICAN SHARED HOSPITAL SERVICES"
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T13:23:29.568315+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# American Shared Hospital Services Q2 net loss $0.02/share; revenue up 10.6% to $5.6M; announces 3rd Gamma Knife order

## Summary
- Net loss of $111,000 ($0.02 diluted EPS) vs net income of $497,000 ($0.08) in Q2 2022.
- Revenue increased 10.6% to $5.57M; gross margin 45.2% vs 41.5% a year ago.
- Operating loss of $325,000 vs operating income of $793,000; reflects $578K impairment reserve from two non-renewed GK agreements.
- Announced third Gamma Knife Esprit order for 2023; international center installations progressing (Mexico/LINAC, Ecuador/ICON, Peru/Esprit).
- Cash grew to $13.8M; adjusted EBITDA $1.94M vs $2.13M in Q2 2022.

## SEC filing metadata
- accession: 0001437749-23-023719
- form_type: 8-K
- ticker: AMS
- cik: 0000744825
- company_name: AMERICAN SHARED HOSPITAL SERVICES
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744825/000143774923023719/0001437749-23-023719-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744825/000143774923023719/asha20230814_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-023719
- JSON: https://secwatch.observer/filing/0001437749-23-023719.json
- Plain text: https://secwatch.observer/filing/0001437749-23-023719.txt

## Key facts
- Earnings Releases
  AMERICAN SHARED HOSPITAL SERVICES reported second quarter ended June 30, 2023 results: revenue $5,568,000.
  - Period: second quarter ended June 30, 2023
  - Revenue: $5,568,000
  - Result: reported results
  source text: systems and services, today announced financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights ● Total revenue in the second quarter was $5,568,000, an increase of 10.6% from the comparable period in 2022. Total proton therapy revenue increased 10.3% period-over-period; fractions increased 3.5%. Gamma Knife revenue increased
  evidence_url: https://www.sec.gov/Archives/edgar/data/744825/000143774923023719/0001437749-23-023719-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.